Acorda Therapeutics Acquires Civitas Therapeutics for $525,000,000

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2c29f799-022d-47f4-a179-9c25c3e5ccb9
Date
9/24/2014
Company Name
Civitas Therapeutics
Mailing Address
190 Everett Ave. Chelsea, MA 02150 USA
Company Description
Civitas is a pharmaceutical company focused on developing products with a clinically proven dry powder pulmonary delivery platform. The proprietary dry powder and device combination is unique in its ability to deliver a large, precise dose independent of inspiratory flow rate from a simple, passive device.
Website
http://www.civitastherapeutics.com
Transaction Type
M&A
Transaction Amount
$525,000,000
Transaction Round
Proceeds Purposes
M&A Terms
Acorda Therapeutics announced that it entered into an agreement to acquire Civitas Therapeutics, a privately-held biopharmaceutical company, for $525 million in cash.